Organization · Venture Capital
PagodaTree Partners
PagodaTree Partners is a China-based venture capital and private equity fund manager founded in 2019, focusing on innovations in life sciences, healthcare, and technology. The firm engages in growth-stage investments and emphasizes social responsibility in its investment strategy.
Overview
What PagodaTree Partners does
What PagodaTree Partners is
PagodaTree Partners is a China-based venture capital and private equity fund manager founded in 2019, focusing on innovations in life sciences, healthcare, and technology. The firm engages in growth-stage investments and emphasizes social responsibility in its investment strategy.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find PagodaTree Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
PagodaTree Partners as a funder
Investment thesis
PagodaTree Partners invests in healthcare and technology innovations, focusing on companies with deep technical differentiation that can address major unmet clinical or industrial problems. The firm seeks to create defensible category leaders in life sciences, biotech, and clean energy.
Focus narrative
PagodaTree Partners primarily invests in the healthcare and life sciences sectors, as well as technology innovation and related interdisciplinary fields. The firm engages in growth-stage investments, mergers and acquisitions, and early-stage investments, actively seeking special investment opportunities and collaborating closely with entrepreneurs to create value and build an ecosystem around its investment philosophy.
Value beyond capital
PagodaTree Partners adds value to its portfolio companies through strategic guidance, leveraging its extensive network in healthcare and technology sectors, and fostering collaborations that enhance growth and innovation. The firm emphasizes long-term partnerships with entrepreneurs to build sustainable business ecosystems.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Growth Equity
- Regions
- Asia · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Notable portfolio companies include: 1. NextPoint Therapeutics - Focused on precision immuno-oncology programs. 2. Simnova - Engaged in CAR-T and CAR-NK cell therapy. 3. Syndeio Biosciences - Developing synapse-targeted therapeutics for CNS disorders. 4. Wison Energies / Wison Clean Energy - Investing in clean-energy equipment.
Common questions
What to know about PagodaTree Partners
Upseed classifies PagodaTree Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.